Having Trouble Quitting Smoking? Cigarettes With Low Nicotine Levels Could Be The Solution

Updated Jan 15, 2025 | 09:01 AM IST

SummaryNicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.
Low-nicotine level of cigarettes

Cigarettes with ultralow nicotine levels are now being called the game-changer in the fight against smoking. If you are having trouble in quitting smoking, then, it is for you, that soon the Biden White House is expected to formally propose a plan that will order cigarette nicotine levels to be reduced, reports The Washington Post. For now though, it has been a failure, as these cigarettes, also known as VLN cigarettes that stands for very low nicotine are only available in 5,100 stores in 26 states. This is a very small fraction of the overall market for cigarettes. The company that makes it, 22nd Century, is struggling not because of the low supply, but also from the advocates who have long believed slashing nicotine levels altogether.

The Advent and ideation

Nicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.

Ultralow-nicotine cigarettes, like the VLN brand, contain about 95% less nicotine than the regular cigarettes. The idea is quite simple: without the addictive grip of nicotine, smokers will find it easier to quit. Research too has shown some promise. For instance, the studies funded by the National Institute on Drug Abuse revealed that very low nicotine cigarettes reduced addiction potential significantly without having users to increase their smoking frequency. However, the problem is, why would anyone choose for a low-nicotine that does not make them feel the same way, when the high-nicotine cigarette is right next to it, making them feel the same way, with the same alertness, sold at the same price.

“It’s very hard to imagine someone actively choosing to continue to use a low-nicotine product for the same price when a high-nicotine product is right next to it,” said Eric Donny, a Wake Forest University School of Medicine nicotine researcher.

No wonder, the experiment with low nicotine product by Philip Morris' Next cigarettes in the 1980s and Vector Tobacco's Quest brand in the early 2000s, flopped.

FDA's Role in the Push

The Food and Drug Administration (FDA) has supported the development of such products, even allowing VLN cigarettes to be marketed as lower-risk options. However, these products remain a niche market, available in only a fraction of U.S. stores.

Recently, the Biden administration has considered a bold step—mandating a dramatic reduction in nicotine levels for all cigarettes sold in the United States. Supporters believe this move could save millions of lives, while critics, including tobacco companies, warn of potential unintended consequences.

What Could Be The Challenges?

Resistance from Big Tobacco Companies: They could argue that slashing nicotine levels could backfire. Their claim is, smokers will turn to black markets or smoke more to satisfy their cravings, which may lead to greater exposure to harmful substances.

Consumer Reluctance: History is proof to the instances of smokers being hesitant to embrace the low-nicotine products.

Political Hurdle: It may face political roadblocks, as under the Trump administration, plans to cut nicotine were shelved.

Could Low-Nicotine Cigarettes Be The Solution?

Advocates believe that ultralow-nicotine cigarettes could be a game-changer, comparing them to decaf coffee or non-alcoholic beer—products that reduce harm while offering a similar experience.

Some experts warn that a black market for traditional cigarettes could undermine these efforts. They also stress the need for safer alternatives, such as vaping products, to support smokers transitioning away from traditional cigarettes.

End of Article

Cholera Outbreak In Nigeria: Death Toll Crosses 39, Cases Exceed 4,200

Updated Jun 7, 2026 | 09:00 PM IST

SummaryNigeria is facing a growing outbreak of cholera, which has already taken about 39 lives and infected 4204 people. The impacted area is the northeastern state of Borno and the surrounding Jere district.
Cholera Outbreak In Nigeria: Death Toll Crosses 39, Cases Exceed 4,200

Credit: AI Generated Image

Nigeria is witnessing an outbreak of cholera, and to curb the spread of the disease, the police there have ordered sanitation measures in the northeastern state of Borno. According to the local media and authorities, about 39 people have died due to the waterborne disease. Local authorities have also reported at least 4,204 cases of infection.

According to the local health authorities, the outbreak is spreading in the Borno capital, Maiduguri, and the surrounding Jere district. The state police commissioner "has directed the full enforcement of the monthly environmental sanitation exercise." The statement added, "Residents are therefore urged to actively participate in the exercise by cleaning their homes, business premises, drainage channels, and surrounding environments."

He added, "To ensure compliance, police personnel and other relevant stakeholders will be deployed to strategic locations across the state during the sanitation period."

The nation is very cautious about the outbreak and has taken several steps to contain the disease as much as possible. The state government has set dedicated treatment centers for public convenience. Notably, cholera is spread by bacteria-tainted water and food, which can easily cause dehydration and diarrhoea.

The advent of modern sewerage systems has eradicated diseases throughout the modern world. Though war, conflict, and social unrest in nations like Nigeria and Sudan result in these unfortunate outbreaks, which take thousands of lives and affect many families.

As Ebola is spreading in African nations of the Democratic Republic of the Congo (DRC) and Uganda, another breakout of Cholera in Nigeria is showing the vulnerabilities of how rampant it is in Africa.

What Is Cholera?

According to the Centers for Disease Control and Prevention (CDC), it is caused by the bacterium Vibrio cholerae. This can be transmitted through drinking water or eating food that contains the bacteria. While most people who get cholera don't get sick, it can cause life-threatening diarrhea and vomiting.

CDC notes that each year, 1.3 to 4 million people around the world get cholera. Among them, 21,000 to 143,000 people die.

What Are The Common Symptoms?

The common symptoms include:

  • watery diarrhea
  • vomiting
  • leg cramps
  • losing body fluids
  • dehydration and shock

Usually, people develop symptoms within 1 to 10 days of consuming the bacteria.

Who Is At More Risk?

People who live in areas with unsafe drinking water, poor sanitation, and inadequate hygiene are at the highest risk of getting cholera. The disease can spread quickly in areas where sewage and drinking water are not adequately treated. It can also live in brackish water, which is slightly salty, or in coastal water. Thus, eating raw shellfish can also cause cholera.

End of Article

Could AI's Universal Coronavirus Vaccine Strategy Lead To An Ebola Breakthrough?

Updated Jun 7, 2026 | 07:00 PM IST

SummaryThe University of Cambridge and the company DIOSynVax have completed the human clinical trial of a universal coronavirus vaccine by using only artificial intelligence (AI) and machine learning.
Could AI's Universal Coronavirus Vaccine Strategy Lead To An Ebola Breakthrough?

Credit-Canva

COVID-19, a name that can trigger a plethora of bad memories and constant fear, a time of solitude and captivity. Though now a breakthrough in medical science connected with coronavirus is giving hope to the possible prevention of Ebola. The universal vaccine was designed entirely by artificial intelligence (AI), and more importantly, it was successful.

It was the first time an AI-designed vaccine has completed a human clinical trial. The results of the trials were published in the Journal of Infection, and according to that report, phase one of the trial was observed by 39 healthy adult volunteers aged 18 to 50 and demonstrated a 100 pc safety profile.

The study stated that this vaccine was developed by the research team at the University of Cambridge and the company DIOSynVax, and they claimed that their vaccine has strong immune responses against various coronavirus strains.

And with this very crucial discovery in medical science, there is also a hope for designing a very effective vaccine for Ebola. Essentially, offering a proactive shield against a disease that continues to pose a significant global public health risk.

How Will This Breakthrough Contribute To The Development Of An Ebola Vaccine?

The vaccines that are traditional often tend to be reactive in nature, which means they can only work on a particular strain of a virus, and as a result, when the virus mutates and evolves, it becomes obsolete.

Artificial intelligence or machine learning can make a big difference in this aspect as it scans the genetic sequences of an entire family of viruses. The development of a universal COVID vaccine followed the same process. The AI pointed out the core features common to all of them, including strains that haven't even crossed over to humans yet, and after that, it has designed the new vaccine.

Though this very vaccine will not directly work on Ebola, the same process and technology can be used to create a similar vaccine in record time for Ebola as well. As the situation of the disease worsens by the day, it has crossed 500 cases.

As of Saturday, the Democratic Republic of the Congo (DRC) reported that its total number of Ebola cases had increased to 488 from 452 cases and caused 86 deaths. Its neighbor, Uganda, also has reported 19 cases.

This time, the Ebola outbreak has caused most harm to the Democratic Republic of the Congo (DRC), and during this mayhem, its neighboring nation, Uganda, which is also fighting to contain the disease as it is also seeing a surge in cases, has completely closed off its western border with DRC.

The World Health Organization (WHO) has declared the outbreak an international public health emergency, and the Centers for Disease Control and Prevention (CDC) warned that the Ebola outbreak of this time could swell to become the largest Ebola epidemic in history.

End of Article

Ebola Outbreak Crosses 500: CDC Warns This Could Become The Largest Epidemic On Record

Updated Jun 7, 2026 | 11:00 AM IST

SummaryThe Ebola outbreak has crossed 500 infected cases as the Democratic Republic of the Congo (DRC) has reported a total of 488 cases and Uganda another 19.
Ebola Outbreak Crosses 500: CDC Warns This Could Become The Largest Epidemic On Record

Credit: AI Generated Image

The situation regarding the outbreak of Ebola is nowhere near slowing down, and the World Health Organization (WHO) said that this outbreak of Ebola is far from under control. The outbreak of the disease in eastern Democratic Republic of the Congo (DRC) and neighboring Uganda has already reached the 500 mark.

On Saturday, the Democratic Republic of the Congo (DRC) reported that its total number of Ebola cases had increased to 488 from 452 cases and caused 86 deaths. Its neighbor, Uganda, also has reported 19 cases.

This time the Ebola outbreak has caused most harm to the Democratic Republic of the Congo (DRC) and during this mayhem its neighboring nation Uganda which is also fighting to contain the disease as it is also seeing surge in cases thus it has completely closed off its western border with DRC.

The worsening condition of the situation is clear, as the global health monitoring organization, the World Health Organization (WHO), has already declared the outbreak an international public health emergency.

And it's not only the case with WHO, another big name in public health, but the United States' Centers for Disease Control and Prevention (CDC) warned that the Ebola outbreak of this time could swell to become the largest Ebola epidemic to date, and is likely to rival the 2014-2016 epidemic in West Africa.

The patient number is still growing as the disease is spreading, and this spread is very hard to contain without an approved vaccine. Though work on the vaccine is in full swing, research on three different vaccines for the Bundibugyo strain of Ebola still needs time, even after being set to be fast-tracked for trials.

What Is Ebola?

Ebola is a severe and deadly disease caused by a virus mostly found in Africa. The spread of the disease happens through contact with infected body fluids.

Some symptoms can indicate a possible infection. This includes fever, headache, weakness, vomiting, diarrhea, muscle pain, sore throat, and unexplained bleeding. This eventually leads to severe complications like bleeding, organ failure, and death.

Ebola is a highly lethal viral hemorrhagic fever first identified in 1976. Over the past five decades, it has caused over 30 outbreaks, primarily in Central and West Africa. The virus takes its name from the Ebola River in the Democratic Republic of the Congo (DRC).

Three strains of the virus — Ebola virus, Sudan virus, and Bundibugyo virus — have caused the largest outbreaks in Africa. Among them, the Ebola virus is considered the deadliest, with fatality rates reaching up to 90% without treatment.

These viruses have repeatedly emerged from animal reservoirs and infected humans in African countries. In the Democratic Republic of the Congo alone, this marks the 17th Ebola outbreak and the third linked to the Bundibugyo strain.

End of Article